Zevra Therapeutics, Inc. (ZVRA) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon and thank you for joining Zevra's second quarter 2025 financial results and corporate update conference call. Today's call is being recorded and will be available via the investor relations section of the company's website later today. The host for today's call is Nicole Oshner, Zevra's vice president of investor relations and corporate communications. Please go ahead. Thank you and welcome to those who are joining us. Today, we will provide an overview of our recent accomplishments, followed by a review of our second quarter financial results. I encourage you to read our financial news release, which was distributed this afternoon and is available in the investor relations section of our website. Before we begin the call, please note that certain information shared today will include forward-looking statements. Actual results may differ materially from those stated or implied by any forward-looking statements due to risks and uncertainties associated with Devereux's business. Forward-looking statements are not promises or guarantees and are inherently subject to risks, uncertainties, and other important factors that may lead actual results to differ materially from the projections made. and should be evaluated together with the risk factor section in our most recently filed quarterly report on Form 10-Q, annual report on Form 10-K, and other filings with the SEC. In addition, we will disclose certain non-GAAP information on today's call, specifically adjusted net loss and adjusted net loss per share. Reconciling information to GAAP can be found in our financial results news release. I'm pleased to welcome Zebra's management team members participating in today's call. Neal McFarlane, Zebra's President and Chief Executive Officer, Liz Wayne Clifton, our...